Celularity Inc. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
Celularity Inc. (CELU) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $193.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-04-30
- Celularity Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2024-09-30 was $73.00K, a 7200.00% increase year-over-year.
- Celularity Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2024-03-31 was $357.00K, a 573.58% increase year-over-year.
- Celularity Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2023-09-30 was $1.00K.
- Celularity Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2023-06-30 was $33.00K.
- Celularity Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $193.00K, a 55.53% decline from fiscal 2024.
- Celularity Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $434.00K, a 329.70% increase from fiscal 2023.
- Celularity Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $101.00K, a 23.48% decline from fiscal 2022.
- Celularity Inc. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $132.00K.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $193.00K 10-K · filed 2026-04-30 | |||
| 2024-12-31 | $434.00K 10-K · filed 2026-04-30 | |||
| 2024-09-30 | $73.00K 10-Q · filed 2024-12-06 | |||
| 2024-03-31 | $357.00K 10-Q · filed 2024-12-06 | |||
| 2023-12-31 | $101.00K 10-K · filed 2025-05-08 | |||
| 2023-09-30 | $1.00K 10-Q · filed 2024-12-06 | $34.00K derived: sum of 2 quarters · filed 2024-12-06 | $87.00K derived: sum of 3 quarters · filed 2024-12-06 | |
| 2023-06-30 | $33.00K 10-Q · filed 2024-12-06 | $86.00K derived: sum of 2 quarters · filed 2024-12-06 | ||
| 2023-03-31 | $53.00K 10-Q · filed 2024-12-06 | |||
| 2022-12-31 | $132.00K 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |